MEDS
$6.20
Trxade Group
$.10
1.64%
MEDS
Earnings Whisper ®
N/A
4th Quarter December 2020
Consensus:  $0.01
Revenue:  N/A
Monday
Oct 26
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when MEDS reports earnings?
Beat
Meet
Miss

Where is MEDS's stock price going from here?
Up
Flat
Down
Stock chart of MEDS
Analysts
Summary of analysts' recommendations for MEDS
Score
Grade
Pivots
Resistance
$6.81
$6.54
$6.37

$6.11

Support
$5.94
$5.67
$5.50
Tweet
Growth
Description
Trxade Group, Inc. is a web based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories and services. The company's products and services include Web-based pharmaceutical marketplaces comprising Trxade.com and Trxade.com; Pharmabayonline, which offers access to proprietary pharmaceutical data analytics to the United States-based independent pharmacies; RxGuru, a software as a service-based desktop application that provides daily drug pricing and analytics to the independent pharmacists; and Pinnacle Tek, an information technology consulting and staffing solution. Trxade Group, Inc. is based in Lutz, Florida.